CB

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended December 31, 1998, for ACE Limited (Note: The input text identifies the registrant as ACE Limited, despite the user metadata referencing Chubb Ltd). ACE is a holding company providing a broad range of insurance and reinsurance products through subsidiaries in Bermuda, the U.S. (ACE USA), and the U.K. (Lloyd's). The results include the full impact of acquisitions of ACE USA and CAT Limited, which were integrated in early 1998.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net income increased 95% to $238.5 million, driven primarily by a surge in net realized gains on investments ($130.2 million vs. $27.5 million) and higher net investment income ($85.1 million vs. $63.7 million) due to a larger asset base from recent acquisitions.
• Underwriting Performance: The combined ratio improved to 82.7% (from 81.2%), indicating profitable underwriting. The loss ratio decreased significantly to 51.0% (from 59.5%) due to favorable experience in ACE Bermuda and the inclusion of lower-loss businesses (ACE USA, CAT). However, the expense ratio rose to 31.7% (from 21.7%) due to the integration costs of new subsidiaries.
• Cash Flow: Net cash used in operating activities was $71.4 million, a reversal from the $118.7 million provided in the prior year. This was largely due to significant loss payments, including a $100 million payment related to breast implant claims.
• Investment Gains: Realized gains were heavily influenced by equity index futures contracts, which generated $124.9 million in gains as the S&P 500 rose 21.3% during the quarter.

Guidance, Outlook, and Risks

• Major Acquisition: On January 12, 1999, ACE announced an agreement to acquire CIGNA Corporation's property and casualty businesses for $3.45 billion. The deal is expected to close by the end of fiscal 1999 Q3 and will be financed via cash, new equity, debt, and convertible securities. Berkshire Hathaway's National Indemnity will provide $1.25 billion in protection against adverse reserve development.
• Debt Refinancing: In October 1998, ACE USA refinanced a $250 million term loan with $250 million in senior notes (8.63% coupon). A credit default swap was entered into to reduce the effective cost of debt to 6.47%.
• Contingencies:
  • Breast Implant Litigation: The company has paid approximately $470 million to date. Management believes current reserves are adequate, though future developments could require additional reserves.
  • Asbestos/Environmental: Reserves are maintained based on known facts, though estimation remains challenging.
  • Year 2000: The company is substantially on schedule for Y2K compliance, with an estimated total project cost of $4 million. Risks remain regarding trading partners and infrastructure.
• Dividends: A quarterly dividend of $0.09 per share was declared on February 5, 1999.

Investor Verification Checklist

• Verify the closing conditions and regulatory approvals for the $3.45 billion CIGNA acquisition.
• Monitor the adequacy of reserves for breast implant and asbestos claims, given the historical volatility in these areas.
• Assess the sustainability of investment income, noting the significant portion of Q4 1998 gains derived from equity market performance and futures contracts.
• Review the impact of the new $250 million senior notes and credit default swap on future interest expense and liquidity.
• Track the integration progress of ACE USA and CAT Limited to ensure expense ratios stabilize as projected.